Identify Changes to “KIDs List” Meds to Keep Children Safe

January 2026

Improve your pediatric safety practices based on recent updates to the Key Potentially Inappropriate Drugs (KIDs) list.

This is the first revision since the initial KIDs list was published by the US Pediatric Pharmacy Association in 2020.

Review notable changes to help improve pediatric care.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Obesity & Weight Loss Address New GLP-1 Agonist Side Effect Concerns
Biologics Be Familiar With the Laundry List of Uses for Dupilumab
Pediatrics Be Aware of the Role of Jornay PM for ADHD
Education and Training Weave AI Into Your Plan for Precepting Learners
Alzheimer Disease Know the Pros and Cons of Lecanemab for Alzheimer Disease
Pediatrics Identify Changes to “KIDs List” Meds to Keep Children Safe
Hair Loss Get to the Root of Male Pattern Baldness Treatments
NatMed Spotlight Put Claims About Methylene Blue in Perspective